Among alternative ETV4 transcripts identified by Nanopore sequencing, the one with exon 9 skipping was present at a frequency of around 1% in PC3 and RWPE prostate cell line as well as in breast cancer and leukemic cell lines; whereas, in most of the cell lines, all other transcripts have frequency below 0.5%. Here, ETV4 is linked to breast carcinoma.